Jean-Claude Maurel

USPTO Granted Patents = 9 (Patent Applications = 4)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 25(Granted Patents)

Location History:

Castries, FR (2000 - 2022)
Baillargues, FR (2023)

Company Filing History:

Centre National De La Recherche Scientifique

patents

5. 1 out of 279

Universitè De Montpellier

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11793831 - Treatment and prevention of injury due to radiation exposure (2023-10-24),

2. 11278568 - In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system (2022-03-22),

3. 10172954 - Use of a reverse-micellar system for delivering chelators of radionuclides and metals (2019-01-08),

4. 9592218 - Reverse micelle system comprising metal ions and use thereof (2017-03-14),

5. 9452136 - Reverse micelle system comprising nucleic acids and use thereof (2016-09-27),

6. 9173838 - Reverse micelle compositions for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation (2015-11-03),

7. 8877237 - Reverse micelle system comprising nucleic acids and use thereof (2014-11-04),

8. 8637314 - Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof (2014-01-28),

9. 6129924 - Diglyceride and sterol based organometallic complexes and pharmaceutical (2000-10-10),

Title: The Innovative Contributions of Jean-Claude Maurel

Introduction

Jean-Claude Maurel is a notable inventor based in Castries, France. He has made significant contributions to the field of technology and medicine, holding a total of 9 patents. His work primarily focuses on advancements in treatment methods and materials science.

Latest Patents

Among his latest patents, one addresses the treatment and prevention of injury due to radiation exposure. This invention relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system. Another significant patent involves the in situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system. This method allows for the preparation of stable cyano-bridged coordination polymers as metal nanoparticles by mixing at least two reverse micellar systems, each containing at least one metal salt precursor. The invention emphasizes the stabilization of these nanoparticles using a biocompatible reverse micellar system, which acts as a nanoreactor.

Career Highlights

Throughout his career, Jean-Claude Maurel has worked with various companies, including Medesis Pharma and Medesis Pharma SA. His innovative approaches have contributed to advancements in medical treatments and materials.

Collaborations

Some of his notable coworkers include Elsa Compte and Cyril Lavaud. Their collaborative efforts have further enhanced the impact of Maurel's inventions.

Conclusion

Jean-Claude Maurel's contributions to innovation and technology are evident through his patents and collaborations. His work continues to influence the fields of medicine and materials science, showcasing the importance of inventive thinking in addressing complex challenges.

This text is generated by artificial intelligence and may not be accurate.